143 related articles for article (PubMed ID: 38263506)
1. Measuring neurobehavioral side effects of corticosteroids in pediatric acute lymphoblastic leukemia: A scoping review.
Bhasin S; Brown J; Dorste A; Samsel C; Vrooman LM; Muriel AC
Pediatr Blood Cancer; 2024 Apr; 71(4):e30881. PubMed ID: 38263506
[TBL] [Abstract][Full Text] [Related]
2. Psychiatric adverse effects of pediatric corticosteroid use.
Drozdowicz LB; Bostwick JM
Mayo Clin Proc; 2014 Jun; 89(6):817-34. PubMed ID: 24943696
[TBL] [Abstract][Full Text] [Related]
3. Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
Mrakotsky CM; Silverman LB; Dahlberg SE; Alyman MC; Sands SA; Queally JT; Miller TP; Cranston A; Neuberg DS; Sallan SE; Waber DP
Pediatr Blood Cancer; 2011 Sep; 57(3):492-8. PubMed ID: 21560226
[TBL] [Abstract][Full Text] [Related]
4. Adverse neuropsychological effects associated with cumulative doses of corticosteroids to treat childhood acute lymphoblastic leukemia: A literature review.
Pépin AJ; Cloutier-Bergeron A; Malboeuf-Hurtubise C; Achille M; Krajinovic M; Laverdière C; Lippé S; Marcoux S; Sinnett D; Sultan S
Crit Rev Oncol Hematol; 2016 Nov; 107():138-148. PubMed ID: 27823641
[TBL] [Abstract][Full Text] [Related]
5. Potassium supplementation mitigates corticosteroid-induced neuropsychiatric effects in pediatric oncology patients.
Pariury H; Willhoite J; Michlitsch J; Agrawal A
Pediatr Hematol Oncol; 2019 Oct; 36(7):445-450. PubMed ID: 31538841
[TBL] [Abstract][Full Text] [Related]
6. Bone Mineral Metabolism During Chemotherapy in Childhood Acute Lymphoblastic Leukemia: Unexpected Vitamin D Deficiency From Induction Corticosteroids in Acute Lymphoblastic Leukemia.
Gahr K; Sommers N; Bostrom B
J Pediatr Hematol Oncol; 2021 Aug; 43(6):240-241. PubMed ID: 33290292
[No Abstract] [Full Text] [Related]
7. Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia.
Warris LT; van den Akker EL; Aarsen FK; Bierings MB; van den Bos C; Tissing WJ; Sassen SD; Veening MA; Zwaan CM; Pieters R; van den Heuvel-Eibrink MM
Psychoneuroendocrinology; 2016 Oct; 72():190-5. PubMed ID: 27448086
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for steroid-induced adverse psychological reactions and sleep problems in pediatric acute lymphoblastic leukemia: A systematic review.
van Hulst AM; Peersmann SHM; van den Akker ELT; Schoonmade LJ; van den Heuvel-Eibrink MM; Grootenhuis MA; van Litsenburg RRL
Psychooncology; 2021 Jul; 30(7):1009-1028. PubMed ID: 33825231
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and management of corticosteroid-induced hyperglycaemia in paediatric acute lymphoblastic leukaemia.
Gregoriou K; Craigie I; Gibson B; Mason A; Shaikh MG
Pediatr Blood Cancer; 2020 Feb; 67(2):e28085. PubMed ID: 31736211
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroids, behavior, and quality of life in children treated for acute lymphoblastic leukemia; a multicentered trial.
Pound CM; Clark C; Ni A; Athale U; Lewis V; Halton JM
J Pediatr Hematol Oncol; 2012 Oct; 34(7):517-23. PubMed ID: 22735884
[TBL] [Abstract][Full Text] [Related]
11. Steroid-induced ocular hypertensive response in pediatric patients with acute lymphoblastic leukemia.
Sawada M; Takachi T; Watanabe K; Tsuchiya Y; Nishimura K; Hotta Y; Sato M
Jpn J Ophthalmol; 2023 Jul; 67(4):396-401. PubMed ID: 37310574
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for steroid-induced affective disorder in children with leukemia.
Muriel AC; Burgers DE; Treyball AN; Vrooman LM; Adolf E; Samsel C
Pediatr Blood Cancer; 2021 May; 68(5):e28847. PubMed ID: 33305874
[TBL] [Abstract][Full Text] [Related]
13. Steroid-induced Bradycardia During Induction Chemotherapy in Children and Young Adults Diagnosed With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
Duffy C; Hall L; Godown J; Koyama T; Borinstein SC
J Pediatr Hematol Oncol; 2019 Oct; 41(7):537-541. PubMed ID: 30994505
[TBL] [Abstract][Full Text] [Related]
14. The impact of dexamethasone and prednisone on sleep in children with acute lymphoblastic leukemia.
Daniel LC; Li Y; Kloss JD; Reilly AF; Barakat LP
Support Care Cancer; 2016 Sep; 24(9):3897-906. PubMed ID: 27108263
[TBL] [Abstract][Full Text] [Related]
15. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
16. A Bayesian multivariate latent t-regression model for assessing the association between corticosteroid and cranial radiation exposures and cardiometabolic complications in survivors of childhood acute lymphoblastic leukemia: a PETALE study.
Caubet Fernandez M; Drouin S; Samoilenko M; Morel S; Krajinovic M; Laverdière C; Sinnett D; Levy E; Marcil V; Lefebvre G
BMC Med Res Methodol; 2019 May; 19(1):100. PubMed ID: 31088361
[TBL] [Abstract][Full Text] [Related]
17. A Literature Review of Racial Disparities in Overall Survival of Black Children With Acute Lymphoblastic Leukemia Compared With White Children With Acute Lymphoblastic Leukemia.
Eche IJ; Aronowitz T
J Pediatr Oncol Nurs; 2020; 37(3):180-194. PubMed ID: 32089043
[TBL] [Abstract][Full Text] [Related]
18. Does dexamethasone induce more neuropsychological side effects than prednisone in pediatric acute lymphoblastic leukemia? A systematic review.
Warris LT; van den Heuvel-Eibrink MM; den Hoed MA; Aarsen FK; Pieters R; van den Akker EL
Pediatr Blood Cancer; 2014 Jul; 61(7):1313-8. PubMed ID: 24532490
[TBL] [Abstract][Full Text] [Related]
19. Bone health in glucocorticoid-treated childhood acute lymphoblastic leukemia.
Velentza L; Zaman F; Sävendahl L
Crit Rev Oncol Hematol; 2021 Dec; 168():103492. PubMed ID: 34655742
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
